Virginia Citizens Consum. Coun., Inc. v. State Bd. of Pharm.

Citation373 F. Supp. 683
Decision Date21 March 1974
Docket NumberCiv. A. No. 73-336-R.
CourtUnited States District Courts. 4th Circuit. United States District Court (Eastern District of Virginia)
PartiesVIRGINIA CITIZENS CONSUMER COUNCIL, INC., et al., Plaintiffs, v. STATE BOARD OF PHARMACY, et al., Defendants.

James W. Benton, Jr., Hill, Tucker & Marsh, Richmond, Va., Raymond T. Bonner, Washington, D. C., for plaintiffs.

Vann H. Lefcoe, Asst. Atty. Gen. of Virginia, Richmond, Va., Anthony F. Troy, Washington, D. C., for defendants.

Before BRYAN, Senior Circuit Judge and MacKENZIE and MERHIGE, District Judges.

OPINION OF THE COURT

BRYAN, Senior Circuit Judge:

A Virginia law1 is here decried as unconstitutional,2 as well as violative of Federal law3, in imputing "unprofessional conduct" to any pharmacist who "publishes, advertises or promotes" in any manner the "price, fee . . . discount, rebate or credit terms . . . for any drugs which may be dispensed only by prescription". The State Board of Pharmacy may rescind the license of any pharmacist engaging in the forbidden activity. The result is that no such price dissemination prevails in Virginia. Declaration of its invalidity and injunction of its enforcement are requested of us4; we accede.

At once it must be emphasized that the plaint here is that of consumers, not the pharmacists. Again, this suit does not involve the illegitimate use of drugs, or even the free use of legitimate drugs, or the illegal procurement or disposal of them. Only professionally prescribed drugs compounded by professional pharmacists are the subject of this litigation, and then only their prices, entirely devoid of comment or advice as to their healing capabilities.

Plaintiffs comprise a resident of the State, suffering from a disease requiring her to take prescription drugs frequently, and unincorporated associations representing their respective groups who, in many instances, are dependent on prescription drugs. As to their standing to sue, see Flast v. Cohen, 392 U.S. 83, 101, 88 S.Ct. 1942, 20 L.Ed.2d 947 (1968); NAACP v. Button, 371 U. S. 415, 428, 83 S.Ct. 328, 9 L.Ed.2d 405 (1963). Defendants are the Board of Pharmacy, with its individual members, which is responsible for the enforcement of the Virginia law regulating the practice of pharmacy in Virginia.

Plaintiffs complain that the State law precludes them from information as to where prescription drugs may be bought at the least expense, and that there are costly disparities in the amounts charged therefor, but that without knowledge of these differences they cannot take advantage of the lower costs commensurate with their means. They further assert that the ages and physical infirmities of many of the individual plaintiffs prevent their ascertaining the most economical purchase; that a material part of elderly persons' income is laid out on medicine; that at many times the medicine prescribed is vital to their well-being; and that their finances may control where they can procure desperately needed drugs. Consequently, plaintiffs earnestly contend that the enactment is a substantial infringement of their privileges under the First Amendment in withdrawing from them accessibility to the benefits of price publications.

The facts just advanced — but not the legal conclusions — are not disputed. It is stipulated, too, that pharmacy is a profession, its licensing and practice demanding thorough collegiate academic application of several years in preparation for entrance into the professional study, with graduation from an accredited school of pharmacy. Expenditures annually for prescription drugs are vast, running into the billions of dollars. Prices therefor do in truth vary tremendously throughout the State. In substantiation the parties have stipulated:

"22. (a) In Northern Virginia the price of 25 Darvon capsules (standard dosage) ranges from $2.35 to $3.65, a difference of 55%; the price of 40 Achromycin tablets (standard dosage) from $2.50 to $4.70, a difference of 90%; of 40 Tetracycline tablets (standard dosage) from $1.68 to $3.90, a difference of 132%.
(b) In Richmond, the cost of 40 Achromycin tablets ranges from $2.59 to $6.00, a difference of 140%.
(c) In the Newport News-Hampton, Virginia peninsula area the following variations exist:
(1) Tetracycline: $1.20 to $9.00, a 650% difference;
(2) Achromycin: $2.20 to $7.80, a 241% difference;
(3) Darvon: $1.90 to $4.70, a 147% difference."

Danger to the public would not be threatened by the advertisement of prescription drugs, the plaintiffs accent, because every sale must be accompanied by a prescription from a licensed physician. The medication would still be the result of the doctor's diagnosis of the patient. Furthermore, the drug would be the product of a rigidly licensed pharmacist. Consequently, the advertisement, it is further pressed, does not encourage the use of drugs, for they would not thereby become more readily obtainable through price publication. Thus, it is avouched that price advertisement does not either potentially or actually affect the health of the user.

The Argument

Initially, Fourteenth Amendment due process protection was invoked by the plaintiffs on behalf of the consumer. This position is no longer pressed. In a written statement filed with the court at argument, the plaintiffs say they "have concluded that they should not pursue in this Court their position that the Virginia law which prohibits advertising of prescription drug price information violates the Fourteenth Amendment", citing as their reason North Dakota State Board of Pharmacy v. Snyder's Drug Stores, Inc., 414 U.S. 156, 94 S.Ct. 407, 38 L.Ed.2d 379 (1973).5

However, a First Amendment safeguard, constrictive of the State through the Fourteenth, DeJonge v. Oregon, 299 U.S. 353, 364, 57 S.Ct. 255, 81 L.Ed. 278 (1937), is interposed:

"A State shall make no law . . . abridging the freedom of speech, or of the press . . ."

to forestall Virginia's instant stricture. Here the plaintiffs reiterate the circumstances of the sick and needy patients who seek the price information to ease their suffering and perhaps aid their survival. Plaintiffs urge that the First Amendment assures its freedoms to the auditor and reader as stoutly as it does the speaker and writer. Kleindienst v. Mandel, 408 U.S. 753, 762-764, 92 S.Ct. 2576, 33 L.Ed.2d 683 (1972); Stanley v. Georgia, 394 U.S. 557, 564, 89 S.Ct. 1243, 22 L.Ed.2d 542 (1969).

In rebuttal, defendants contend that the First Amendment does not shield commercial speech or writing, and that advertisement of prescription drug prices is a commercial publication, citing Valentine v. Chrestensen, 316 U.S. 52, 54, 62 S.Ct. 920, 86 L.Ed. 1262 (1942). However, rejoin the consumers, the predominant factor here is that the barring of publication could retard access to a means of medical relief for the invalid and thus affront the First Amendment.

The Point for Decision

The controversy here comes, therefore, to whether the State may legally exclude from publication prescription drug prices not otherwise fairly available to those consumers who vitally need the drugs, but who, because of disability, illness or poverty, can only afford the very lowest price.

The Authorities

Validity of the Virginia law, say the defendants, is secured in the able opinion of Patterson Drug Company v. Kingery, 305 F.Supp. 821 (3-judge court, W.D.Va.1969). No infirmity is now ascribed to that decision, but notably there the suit was cast in a context quite the opposite of that pleaded here. In Kingery, the unsuccessful assailants were pharmacists, sellers of the drugs and, of course, theirs was a prima facie commercial approach. The opinion mentions the First Amendment only to note its inapplicability because the case involved commercial advertising. Consumers' consequences, though, understandably were not discussed since they were not raised.

Instantly, the actual suitors are consumers; their concern is fundamentally deeper than a trade consideration. While it touches commerce closely, the overriding worry is the hindrance to a means for preserving health or even saving life. Speaking of Valentine v. Chrestensen, supra, 316 U.S. 52, 62 S.Ct. 920, 86 L.Ed. 1262, the opinion in Pittsburgh Press Co. v. Human Relations Commission, 413 U.S. 376, 384, 93 S.Ct. 2553, 37 L.Ed.2d 669 (1973) somewhat tempers the former's downright exclusion: "Subsequent cases have demonstrated, however, that speech is not rendered commercial by the mere...

To continue reading

Request your trial
11 cases
  • Virginia State Board of Pharmacy v. Virginia Citizens Consumer Council, Inc
    • United States
    • U.S. Supreme Court
    • May 24, 1976
    ...information about entirely lawful activity, fearful of that information's effect upon its disseminators and its recipients. Pp. 771-773. 373 F.Supp. 683, Anthony F. Troy, Richmond, Va., for appellants. Alan B. Morrison, Washington, D. C., for appellees. Mr. Justice BLACKMUN delivered the op......
  • Consumers Union of US, Inc. v. American Bar Ass'n
    • United States
    • U.S. District Court — Eastern District of Virginia
    • December 17, 1976
    ...Three-Judge District Court was empaneled to hear the case pursuant to 28 U.S.C. § 2281. See Virginia Citizens Consumer Council, Inc., et al. v. State Board of Pharmacy, 373 F.Supp. 683 (E.D.Va.1974), aff'd, 425 U.S. 748, 96 S.Ct. 1817, 48 L.Ed.2d 346 (1976). See also Hagens v. Lavine, 415 U......
  • Linmark Associates, Inc. v. Willingboro Tp.
    • United States
    • U.S. Court of Appeals — Third Circuit
    • April 28, 1976
    ...Jan. 6, 1976); see also Millstone v. O'Hanlon Reports, Inc., 528 F.2d 829 (8th Cir. 1976); Virginia Citizens Consumer Council, Inc. v. State Board of Pharmacy, 373 F.Supp. 683 (E.D.Va.1974), prob. juris noted, 420 U.S. 971, 95 S.Ct. 1389, 43 L.Ed.2d 650 (1975) (No. Having taken Valentine v.......
  • Terry v. California State Board of Pharmacy
    • United States
    • U.S. District Court — Northern District of California
    • May 12, 1975
    ...under 65, said information is essential. This same First Amendment claim was recently upheld in Virginia Citizens Consumer Council v. State Board of Pharmacy, 373 F.Supp. 683 (E.D.Va. 1974) (three-judge court), prob. juris. noted, 420 U.S. 971, 95 S.Ct. 1389, 43 L. Ed.2d 650 (1975). There, ......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT